Your browser doesn't support javascript.
loading
Cardiovascular drugs and COVID-19 clinical outcomes: A living systematic review and meta-analysis.
Asiimwe, Innocent G; Pushpakom, Sudeep; Turner, Richard M; Kolamunnage-Dona, Ruwanthi; Jorgensen, Andrea L; Pirmohamed, Munir.
Afiliação
  • Asiimwe IG; The Wolfson Centre for Personalized Medicine, MRC Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, L69 3GL, UK.
  • Pushpakom S; The Wolfson Centre for Personalized Medicine, MRC Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, L69 3GL, UK.
  • Turner RM; The Wolfson Centre for Personalized Medicine, MRC Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, L69 3GL, UK.
  • Kolamunnage-Dona R; Department of Biostatistics, Institute of Population Health Sciences, University of Liverpool, Liverpool, L69 3GL, UK.
  • Jorgensen AL; Department of Biostatistics, Institute of Population Health Sciences, University of Liverpool, Liverpool, L69 3GL, UK.
  • Pirmohamed M; The Wolfson Centre for Personalized Medicine, MRC Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, L69 3GL, UK.
Br J Clin Pharmacol ; 87(12): 4534-4545, 2021 12.
Article em En | MEDLINE | ID: mdl-34101232

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Cardiovasculares / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Cardiovasculares / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article